We reported earlier that prostate cancer cells undergo NED and transdifferentiate into NE-like cells post FIR treatment with the cumulative treatment of 40 Gy (2 Gy/day, 5 days/week) and PRMT5 protein gets upregulated in response to FIR. Here, PRMT5 is linked to prostate carcinoma.